Home
Aerie Pharmaceuticals

Aerie Pharmaceuticals Market Share Analysis for August 2026

our mission is to provide innovative vision products that enhance quality of life by helping people see better. from vision research to eye health, learn more at alcon.com.

Health > Biotechnology and Pharmaceuticals

Domainaeriepharma.com

Year Founded2005

Employees201 - 500

Annual Revenue$100M - $200M

Aerie Pharmaceuticals

Aerie Pharmaceuticals (including company regionals)

aeriepharma.com

See more website traffic and engagement information

Aerie Pharmaceuticals Revenue up to August 2026 is 100M - 200M

revenue generated by Aerie Pharmaceuticals top domains

Aerie Pharmaceuticals top domains revenue over 3 years

Revenue for Aerie Pharmaceuticals top domains

aeriepharma.com100M - 200M

See more with Sales Intelligence

Total visits to Aerie Pharmaceuticals's top domains

Understand Aerie Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Aerie Pharmaceuticals's top domains

Analyze Aerie Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Aerie Pharmaceuticals's top domains

See how Aerie Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Aerie Pharmaceuticals top competitors by domain

Top similar sites in August 2026, ranked by their affinity

parmed.comCompany NameParMed PharmaceuticalsEmployees51 - 200HQUnited States, New York, Niagara FallsAnnual revenue$15M - $25MTotal visits123.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Aerie Pharmaceuticals

These are the website technologies, by industry, used by Aerie Pharmaceuticals top domains

Widget (4)

Twemoji

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

Conversion & Analytics (1)

Google Analytics

More Technologies

7

See all

News & Signals from Aerie Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlcon Components Limited acquires Aerie Pharmaceuticals Inc.Alcon acquired the ophthalmic supplier Aerie Pharmaceuticals for £658m ($770m), adding to its expansion into the ophthalmic eye drop space and to broaden its research and development (R&D) capabilities.

NewsAlcon Switzerland SA acquired Aerie Pharmaceuticals Inc for $770M on Aug 1st '22.That includes Aerie Pharmaceuticals (NASDAQ: AERI), which recently announced it’s being bought by Switzerland-based Alcon (NYSE: ALC) for around $770 million.

NewsAerie Pharmaceuticals Inc hired Peter F. Lang as Chief Financial Officer on Mar 18th '22.Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announced that Peter F. Lang will join the Company as Chief Financial Officer, effective March 18, 2022.